(Q51059137)

27 March 2018

title

Increased tumor-specific CD8+ T cell induction by dendritic cells matured with a clinical grade TLR-agonist in combination with IFN-gamma. (English)

1 reference

27 March 2018

0 references

J Vanderlocht

1

1 reference

27 March 2018

C H M J Van Elssen

2

1 reference

27 March 2018

B L M G Senden-Gijsbers

3

1 reference

27 March 2018

B Meek

4

1 reference

27 March 2018

S Cloosen

5

1 reference

27 March 2018

C Libon

6

1 reference

27 March 2018

G M J Bos

7

1 reference

27 March 2018

W T V Germeraad

8

1 reference

27 March 2018

publication date

1 January 2010

1 reference

27 March 2018

International Journal of Immunopathology and Pharmacology

published in

1 reference

27 March 2018

volume

23

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

35-50

1 reference

27 March 2018

Dendritic cells as therapeutic vaccines against cancer

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

The use of dendritic cells in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Active immunization against cancer with dendritic cells: the near future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Rational approaches to human cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Immunotherapy of cancer with dendritic-cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Harnessing dendritic cells to generate cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Variation matters: TLR structure and species-specific pathogen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

The role of chemokine receptors in primary, effector, and memory immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Cell death mechanisms induced by cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Cytokine control of memory T-cell development and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Enhancement of CD4+ T-cell help reverses the doxorubicin-induced suppression of antigen-specific immune responses in vaccinated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Rules of chemokine receptor association with T cell polarization in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

T(H)-17 cells in the circle of immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Swords into plowshares: IL-23 repurposes tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

In vivo tracking of dendritic cells in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300104

10.1177/039463201002300104

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018